Regeneron Pharmaceuticals (REGN) has secured a landmark FDA approval for its monoclonal antibody garetosmab, now commercially known as Pasatru, after more than ten years in development. The drug becomes the second FDA-cleared
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 6% to 11,872p on Monday, marking the steepest single-day decline across the entire FTSE 100 index. The sell-off came after reports emerged that Britain’s largest drugmaker
More
The FTSE 250 index, which tracks mid-sized companies listed on the London Stock Exchange, has long been considered a barometer of the domestic UK economy. Unlike the FTSE 100, which is heavily
More
AstraZeneca’s shares fell sharply in early trading as investors expressed clear scepticism over a potential merger with US rival Bristol Myers Squibb. The UK drugmaker’s stock dropped six per cent to 11,866p
More
Italy has implemented the EU’s Empowering Consumers for the Green Transition Directive ahead of its bloc-wide application date of 27 September 2026. The implementation was carried out through Legislative Decree No. 30/2026,
More
Legal operations professionals are facing mounting pressure to modernise workflows as artificial intelligence continues to disrupt traditional contract management practices. A forthcoming webinar from Above the Law and Concord will examine how
More
The US stock market is flashing a rare and historically ominous signal, one that has appeared only six times in the past 155 years. Each of the previous five occurrences of this
More
Big Four consultancy EY has raised its UK growth forecast to 0.9 per cent this year, offering a cautiously optimistic outlook for the British economy. However, EY economists have warned that this
More
The Modernization of Cosmetics Regulation Act of 2022, known as MoCRA, introduced sweeping changes to how cosmetics are regulated across the United States. Among its core requirements, MoCRA aligned cosmetics adverse-event record-keeping
More
Washington state has scrapped its entire July NextGen bar exam administration after a convention centre hardware failure left roughly 645 applicants unable to log in. The state has offered affected candidates a
More
Nuclear energy stocks have attracted growing investor interest as the surge in artificial intelligence infrastructure creates enormous new demand for reliable, low-carbon electricity. Data centres powering AI workloads require vast and uninterrupted
More